TAKEDA PHARMACEUTICAL CO LTD (TAK) Insider Trading

Name: TAKEDA PHARMACEUTICAL CO LTD (TAK) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Sep 15, 2026): Duprey Lauren Rusckowski (Chief Transformation Officer): Sale of 34,535 shares, $640.3K.

Get alerted when insiders trade TAK

Email address

Loading company data...

Beta

Loading company details...

Beta